Resilience in Adult Coeliac Patients on a Gluten-Free Diet: A Cross-Sectional Multicentre Italian Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
07 Aug 2024
Historique:
received: 13 06 2024
revised: 17 07 2024
accepted: 20 07 2024
medline: 1 9 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

Data on resilience, the ability to recover from adversity, in coeliac disease (CeD) are lacking. To assess the degree of resilience in patients with CeD on a gluten-free diet (GFD), and its association with clinical features, sociodemographic factors, psychological morbidity, and quality of life (QOL). A cross-sectional multicentre Italian study was conducted on adult CeD patients between May 2022 and April 2023. Connor-Davidson Resilience Scale (CD-RISC), the Coeliac Disease-specific Quality of Life Scale (CD-QOL), the State-Trait Anxiety Inventory scale (STAI-Y), and the Beck Depression Inventory scale (BDI) were used to evaluate resilience, QOL, anxiety, and depression, respectively. A multivariate analysis was conducted to identify factors independently associated with the degree of resilience. A total of 305 patients (221 F, mean age at CeD diagnosis 36 ± 16 years) on a long-term GFD (median 8 years, IQR 3-17) were enrolled. A total of 298/305 patients (98%) had a high level of resilience (CD-RISC ≥ 35). At univariate analysis, resilience was statistically associated with male gender ( Higher trait anxiety predicts lower levels of resilience. Targeted interventions in this subgroup of patients may be helpful for their management and follow-up.

Sections du résumé

BACKGROUND BACKGROUND
Data on resilience, the ability to recover from adversity, in coeliac disease (CeD) are lacking.
AIM OBJECTIVE
To assess the degree of resilience in patients with CeD on a gluten-free diet (GFD), and its association with clinical features, sociodemographic factors, psychological morbidity, and quality of life (QOL).
METHODS METHODS
A cross-sectional multicentre Italian study was conducted on adult CeD patients between May 2022 and April 2023. Connor-Davidson Resilience Scale (CD-RISC), the Coeliac Disease-specific Quality of Life Scale (CD-QOL), the State-Trait Anxiety Inventory scale (STAI-Y), and the Beck Depression Inventory scale (BDI) were used to evaluate resilience, QOL, anxiety, and depression, respectively. A multivariate analysis was conducted to identify factors independently associated with the degree of resilience.
RESULTS RESULTS
A total of 305 patients (221 F, mean age at CeD diagnosis 36 ± 16 years) on a long-term GFD (median 8 years, IQR 3-17) were enrolled. A total of 298/305 patients (98%) had a high level of resilience (CD-RISC ≥ 35). At univariate analysis, resilience was statistically associated with male gender (
CONCLUSIONS CONCLUSIONS
Higher trait anxiety predicts lower levels of resilience. Targeted interventions in this subgroup of patients may be helpful for their management and follow-up.

Identifiants

pubmed: 39203732
pii: nu16162595
doi: 10.3390/nu16162595
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Annalisa Schiepatti (A)

Department of Internal Medicine and Therapeutics, University of Pavia, Italy, 27100 Pavia, Italy.
Gastroenterology Unit of Pavia Institute, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.

Stiliano Maimaris (S)

Department of Internal Medicine and Therapeutics, University of Pavia, Italy, 27100 Pavia, Italy.
Gastroenterology Unit of Pavia Institute, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.

Simona Randazzo (S)

Department of Internal Medicine and Therapeutics, University of Pavia, Italy, 27100 Pavia, Italy.

Daria Maniero (D)

Department of Surgery, Oncology and Gastroenterology, University of Padova, 35128 Padua, Italy.

Roland Biti (R)

Department of Surgery, Oncology and Gastroenterology, University of Padova, 35128 Padua, Italy.

Giacomo Caio (G)

Department of Translational Medicine, St. Anna Hospital, University of Ferrara, 44121 Ferrara, Italy.
Mucosal Immunology and Biology Research Center, Massachusetts General Hospital-Harvard Medical School, Boston, MA 02114, USA.

Lisa Lungaro (L)

Department of Translational Medicine, St. Anna Hospital, University of Ferrara, 44121 Ferrara, Italy.

Antonio Carroccio (A)

Unit of Internal Medicine, "V. Cervello" Hospital, Ospedali Riuniti "Villa Sofia-Cervello", 90146 Palermo, Italy.
Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.

Aurelio Seidita (A)

Unit of Internal Medicine, "V. Cervello" Hospital, Ospedali Riuniti "Villa Sofia-Cervello", 90146 Palermo, Italy.
Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), 90146 Palermo, Italy.

Davide Scalvini (D)

Department of Internal Medicine and Therapeutics, University of Pavia, Italy, 27100 Pavia, Italy.
Gastroenterology Unit of Pavia Institute, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.

Carolina Ciacci (C)

Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, 84081 Salerno, Italy.

Federico Biagi (F)

Department of Internal Medicine and Therapeutics, University of Pavia, Italy, 27100 Pavia, Italy.
Gastroenterology Unit of Pavia Institute, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.

Fabiana Zingone (F)

Department of Surgery, Oncology and Gastroenterology, University of Padova, 35128 Padua, Italy.
Unit of Gastroenterology, Azienda Ospedale Università Padova, 35128 Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH